Back to Search
Start Over
Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia
- Source :
- European Journal of Clinical Pharmacology; September 1994, Vol. 47 Issue: 2 p133-138, 6p
- Publication Year :
- 1994
-
Abstract
- The efficacy and safety of lifibrol, a novel cholesterol-lowering drug, was investigated in a double-blind clinical study in 168 patients with primary hypercholesterolaemia. Placebo and four lifibrol dose groups (150, 300, 450 and 600 mg/day) were tested over a period of 4 weeks.
Details
- Language :
- English
- ISSN :
- 00316970 and 14321041
- Volume :
- 47
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- European Journal of Clinical Pharmacology
- Publication Type :
- Periodical
- Accession number :
- ejs16150111
- Full Text :
- https://doi.org/10.1007/BF00194962